November 5, 2010 – The U.S. Food and Drug Administration (FDA) has given 510(k) clearance for an advanced dose calculation algorithm. The Acuros XB, by Varian Medical Systems, can complete a RapidArc treatment plan two to three times faster than conventional algorithms.

November 5, 2010 – A new system can significantly cut radiotherapy treatment times. Creekside Cancer Center said the CyberKnife VSI system, by Accuray International, reduced the average treatment time to less than 30 minutes. Creekside is the first facility to install and use the system.

November 5, 2010 – A new PACS module incorporates industry-leading high-definition volume rendering (HDVR) software. IntelePACS 3D, by Intelerad, uses Fovia’s HDVR system.

High performance volumetric rendering is important as the amount of data acquired by modern modalities increases and as teleradiology becomes more popular.

November 5, 2010 – As part of the U.S. government’s Therapeutic Discovery Project, Orbital Therapy has been awarded nearly $250,000 for a breast cancer research project.

November 5, 2010 - The U.S. Food and Drug Administration (FDA) granted 510(k) clearance for the latest version of a cardiovascular ultrasound system. The GE Healthcare Vivid E9 Breakthrough 2011 (BT11) is built for 4-D imaging and features elements designed to help improve image quality, quantification and workflow.

November 4, 2010 - A smaller, more efficient and cost-effective proton therapy system will soon be available for cancer treatment centers. The single-room Proteus One system, from IBA Particle Therapy, is roughly one-third the size of the current gantry configuration.

November 4, 2010 – The U.S. Food and Drug Administration (FDA) has cleared a high-resolution computed radiography (CR) system for mammography. The Directview CR system, by Carestream, is intended for use in the same clinical applications as traditional screen-film based mammography systems.

November 4, 2010 – Several new radiation oncology tools were on display at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in San Diego, Calif. The tools, by Philips, include 4-D imaging, a toolkit to evaluate organ motion and technology to help clinicians view critical structures near the sites of dense metal objects.


Prostate disease is primarily evaluated by using digital rectal examination (DRE) in combination with other clinical data including prostate-specific antigen (PSA) tests and pathologic information. These commonly used diagnostic tests have been shown to result in both high false positive and high false negative results.

November 4, 2010 – A new magnetic resonance (MR) imaging for oncology use was introduced at the American Society for Therapeutic Radiology and Oncology (ASTRO) meeting in San Diego, Calif. The Panorama High Field Open (HFO) Oncology Configuration, by Philips, combines the soft tissue contrast of MR with a spacious patient aperture.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now